Archive - November 2009

• Cardiologists question warning on clopidogrel/omeprazole interaction (24/11/2009)
• STEMI and PCI guidelines updated (24/11/2009)
• Disparity in ACS management of patients with diabetes (24/11/2009)
• More evidence for warfarin alternative (24/11/2009)
• HDL protects against CVD in diabetes (24/11/2009)
• Male drinkers can take heart from new findings (24/11/2009)
• New device allows therapeutic hypothermia before hospitalisation (18/11/2009)
• Slow walkers more susceptible to CV death (18/11/2009)
• No benefit from new antiplatelet agent in PCI (18/11/2009)
• Iron deficiency a new therapeutic target in heart failure? (18/11/2009)
• Higher losartan doses best in HF (18/11/2009)
• HDL raising with niacin superior to ezetimibe: ARBITER 6-HALTS (17/11/2009)
• Biventricular pacing protects against cardiac remodeling (17/11/2009)
• Statin alternative for PBS (11/11/2009)
• British report finds lack of senior doctor involvement (11/11/2009)
• Clopidogrel gender differences not statistically significant (11/11/2009)
• Low carb diet leads to unhappy weight loss (11/11/2009)
• Aspirin benefit lower in diabetes (11/11/2009)
• Top of the list for wining and dining (10/11/2009)
• Intermediate-risk NSTE-ACS at highest risk (10/11/2009)
• Trial of CPR for out-of-hospital arrest stopped (10/11/2009)
• Interventional cardiologist dies (10/11/2009)
• Lower doses may improve outcomes in chronic disease (04/11/2009)
• Aspirin not justified in primary prevention (04/11/2009)
• ESAs no benefit in diabetes patients with CKD (04/11/2009)
Displaying results 1-25 (of 28)
 |<  < 1 - 2  >  >| 

Back to archive ...